UTERINE NEOPLASMS
Clinical trials for UTERINE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UTERINE NEOPLASMS trials appear
Sign up with your email to follow new studies for UTERINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers with AKT1 mutation
Disease control OngoingThis early-stage study tests an experimental pill, ATV-1601, in people with advanced solid tumors (including certain breast, ovarian, and prostate cancers) that have a specific AKT1 gene mutation. The main goals are to check the drug's safety, find the best dose, and see how the …
Matched conditions: UTERINE NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a combination of two drugs, tucatinib and trastuzumab, in people with advanced solid tumors that have HER2 alterations. The goal is to see if the treatment can shrink or control the cancer. About 217 participants with various cancer types, including lung, uterine…
Matched conditions: UTERINE NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 26, 2026 11:29 UTC